Physician profile
Michael Jacob Horwitz
NPI 1386842987
$6,756.45
in general payments reported to CMS, 2019-2025
37 companies · $848 in 2025
The $848 reported for 2025 was more than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $675 · 2021: $681 · 2022: $1,246 · 2023: $952 · 2024: $1,442 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,242.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $799.13 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $772.01 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $697.77 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $634.25 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $454.38 | 2019-2024 | |
| Atricure, INC. | $413.39 | 2022-2024 | |
| Boston Scientific Corporation | $387.99 | 2019-2025 | Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $368.67 | 2021-2025 | Verquvo, Capvaxive |
| Impulse Dynamics (USA) INC. | $341.23 | 2019-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $305.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $227.45 | 2019-2023 | Xarelto |
| W. L. Gore & Associates, INC. | $192.75 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $135.89 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.67 | 2023-2025 | Jardiance |
| Abiomed | $128.20 | 2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Horwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.